Biotechnology Companies By Current Ratio
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Ratio
| Current Ratio | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | SBFM | Sunshine Biopharma | (0.04) | 4.81 | (0.19) | ||
| 2 | GHRS | GH Research PLC | 0.08 | 10.58 | 0.89 | ||
| 3 | SBFMW | Sunshine Biopharma Warrant | 0.15 | 44.59 | 6.87 | ||
| 4 | PMCB | PharmaCyte Biotech | 0.04 | 3.55 | 0.15 | ||
| 5 | GLSI | Greenwich Lifesciences | (0.10) | 3.07 | (0.31) | ||
| 6 | RZLT | Rezolute | (0.06) | 3.93 | (0.25) | ||
| 7 | CELZ | Creative Medical Technology | 0.16 | 7.37 | 1.16 | ||
| 8 | XENE | Xenon Pharmaceuticals | (0.09) | 2.07 | (0.19) | ||
| 9 | KTTA | Pasithea Therapeutics Corp | (0.18) | 7.06 | (1.30) | ||
| 10 | TYRA | Tyra Biosciences | (0.10) | 3.03 | (0.30) | ||
| 11 | NAUT | Nautilus Biotechnology | (0.16) | 3.94 | (0.65) | ||
| 12 | DSGN | Design Therapeutics | (0.03) | 5.97 | (0.21) | ||
| 13 | SNPX | Synaptogenix | 0.00 | 5.37 | 0.01 | ||
| 14 | BCTX | Briacell Therapeutics Corp | (0.17) | 9.72 | (1.66) | ||
| 15 | EPIX | ESSA Pharma | (0.04) | 2.12 | (0.08) | ||
| 16 | DRTS | Alpha Tau Medical | 0.01 | 3.87 | 0.04 | ||
| 17 | AVTE | Aerovate Therapeutics | (0.07) | 1.92 | (0.13) | ||
| 18 | LEXX | Lexaria Bioscience Corp | (0.09) | 5.16 | (0.46) | ||
| 19 | KZR | Kezar Life Sciences | (0.14) | 2.44 | (0.33) | ||
| 20 | SVRA | Savara Inc | (0.09) | 3.67 | (0.34) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company. Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).